Mark Cuban, billionaire entrepreneur and owner of Landmark Theaters, Magnolia Pictures, and the Dallas Mavericks, has now dipped his toe into mobile health investing. After making a $500,000 investment in smartphone-connected breathalyzer Breathometer on ABC’s Shark Tank, Cuban has now participated in Validic‘s $760,000 seed round. “Personalized health is the future of healthcare,” Cuban said [...]
Technology from Baltimore-based WellDoc has successfully demonstrated the ability to predict hypoglycemia (a dangerously low blood sugar level) in patients with type 2 diabetes, according to a company announcement. WellDoc researchers tested a prediction model using tens of thousands of blood glucose data points from both the International Diabetes Center and WellDoc's proprietary databases. What they learned was that by using seven days of spot blood glucose monitoring data, with about one blood glucose test per day, WellDoc's technology can send an alert for hypoglycemic events that are likely to occur within the next 24 hours, claims the company. Initial results of the company's hypoglycemia prediction model were presented on Oct. 31 during the scientific poster session at the 2013 Diabetes Technology Society Meeting in San Francisco.